Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
University of California San Francisco researchers uncover common immune microenvironments across different types of cancer.
A look back at some of the most important science and treatment news Cancer Health covered this year.
Most never smokers who develop lung cancer have tumor mutations that make them eligible for precision medicine.
A new generation of precision cancer therapies are easier to tolerate than traditional treatment.
Data from early clinical trials suggest new precision cancer treatments are on the horizon.
For Childhood Cancer Awareness Month, the National Cancer Institute’s Director Dr. Ned Sharpless reflects on childhood cancer progress.
For people with cancer being treated with chemo drugs in the class fluoropyrimidines, DPD testing can be lifesaving.
Genomic testing can help customize treatment to target tumors.
Black patients should also benefit from recently approved PARP Inhibitor therapies “if applied equitably,” study finds
The latest research on healthy life and prevention, improving outcomes, reducing side effects and getting the best precision medicine.
Betting on basic science is leading to breakthroughs in immune checkpoint inhibitors, CAR-T, targeted therapies, cancer vaccines and more.
One in three dogs will develop cancer during their lifetime, and pet owners are looking for treatments.
We look forward to working with our many stakeholders to make the promise of precision medicine a reality for more people.
The discovery points the way toward a new strategy for precision cancer therapy.
The agency clarifies how test developers may use clinical evidence in public databases to show that their test is “clinically valid.”
Next-generation medications have made chronic conditions out of previously fatal cancers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.